News Pfizer Inc.

Stocks

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 15:46:45 15/06/2026 BST			5-day change	1st Jan Change
26.36 ^USD	+0.55%		+2.79%	+5.76%

11:56am	Global drugmakers invest billions to boost US presence	RE
06-12	Drugmakers will not be exempt from cost cuts, says German health minister	RE

All News

Mentions Relevance

06-12	Drugmakers will not be exempt from cost cuts, says German health minister	RE
06-11	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
06-11	Race to launch weight-loss pill heats up as Novo wins UK approval	RE
06-11	Commission's appeal against COVID vaccine contract disclosures should be dismissed, court adviser says	RE
06-10	Pfizer's Risk-Reward More Balanced Ahead of 2 Key Pipeline Catalysts, RBC Capital Markets Says	MT
06-10	Pfizer CEO warns German investment at risk over drug pricing policies	RE
06-10	RBC Upgrades Pfizer to Sector Perform from Underperform, PT is $25	MT
06-09	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
06-08	Pfizer Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08:00 AM
06-08	U.S. FDA Approves Pfizer?s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need	CI
06-08	Pfizer Gets FDA Expanded Hympavzi Approval	DJ
06-08	Pfizer Says US FDA Expands Hemophilia Drug Approval to Younger Patients	MT
06-08	US FDA approves Pfizer's bleeding disorder drug for children	RE
06-08	U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need	BU
06-06	Pfizer Presents Detailed Results From Multiple Phase 2b Studies Of Berobenatide And Plans To Advance 10 Phase 3 Studies For Chronic Weight Management And Obesity-Related Comorbidities	CI
06-06	Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial	RE
06-06	Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide	BU
06-04	Data Feed - Faktencheck: Hantavirus-Infektion ist keine Nebenwirkung des COVID-Impfstoffs von Pfizer	RE
06-03	Pfizer Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 02:00 PM
06-01	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference	BU
06-01	Pfizer's Braftovi Regimen Cuts Risk of Progression, Death in Phase 3 Trial in Colorectal Cancer	MT
06-01	PFIZER INC : Jefferies remains its Buy rating	ZD
06-01	PFIZER INC : JP Morgan remains Neutral	ZD
05-31	Pfizer : BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer	PU
05-31	Pfizer Inc. Announces Detailed Progression-Free and Overall Survival Results from Cohort 3	CI